NeoGenomics, Inc. Repayments of Convertible Debt
NeoGenomics, Inc. (NEO) reported Repayments of Convertible Debt of $262.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2026-07-28
- NeoGenomics, Inc. repayments of convertible debt for the quarter ending 2025-12-31 was $0.00.
- NeoGenomics, Inc. repayments of convertible debt for the quarter ending 2025-09-30 was $0.00.
- NeoGenomics, Inc. repayments of convertible debt for the quarter ending 2024-12-31 was $0.00.
- NeoGenomics, Inc. repayments of convertible debt for the quarter ending 2024-09-30 was $0.00.
- NeoGenomics, Inc. repayments of convertible debt for fiscal 2025 was $201.25M.
- NeoGenomics, Inc. repayments of convertible debt for fiscal 2024 was $0.00.
- NeoGenomics, Inc. repayments of convertible debt for fiscal 2023 was $0.00.
| Period end | Repayments of Convertible Debt 3 month | Repayments of Convertible Debt 6 month | Repayments of Convertible Debt 9 month | Repayments of Convertible Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $262.89M 10-Q · filed 2026-07-28 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $201.25M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $201.25M 10-Q · filed 2025-10-28 | ||
| 2025-06-30 | $201.25M 10-Q · filed 2026-07-28 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 derived: sum of 2 quarters · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $0.00 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-07-29 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |